Skip to main content
. Author manuscript; available in PMC: 2023 Sep 15.
Published in final edited form as: Toxicol Appl Pharmacol. 2022 Jul 8;451:116161. doi: 10.1016/j.taap.2022.116161

Fig. 11. Specific ncRNA markers of prenatal BPA exposure in muscle:

Fig. 11.

The OPLS-DA S-Plots for ncRNA (lncRNA, miRNA, and snoRNA) from muscle showing potential ncRNA markers of prenatal BPA-treatment. The up and down arrow represents the upregulated and downregulated genes with prenatal BPA-treatment, each point represents a non-coding RNA with pink and blue points representing the potential signatures of prenatal BPA-treatment.